$4.33
Today
as of Jul 22, 16:45 ET
Last 30 days
Recent Press Releases & News
Arbutus, Sanofi escalate mRNA patent fights; InnoCare’s TYK2 contender advances
ABUS Stock On Track For Best Day In About Two Months — What’s The Moderna Connection?
Arbutus Biopharma, Genevant sue Pfizer, BioNTech Over Lipid Nanoparticle Patents
Overview
52-week range
$3.04
$5.10
63% of range
Avg surprise (last 2)
+52.8%
Avg reaction (last 2)
-0.5%
0% positive
Latest IV / EM
86%
EM ±19.6% · $4 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Wed May 13, 2026 | Mar/2026 | $0.87 | — | — | +769.2% | 0.0% | earnings |
| Wed Aug 6, 2025 | Jun/2025 | $0.01 | $-0.02 | +150.0% | — | — | earnings |
| Wed May 14, 2025 | Mar/2025 | $-0.13 | $-0.09 | -44.4% | — | -0.9% | earnings |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Wed Aug 5, 2026 | Jun/2026 | OTHER | — | $0.01 |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $179M | — | $529,000 | $11M | $2M | — | $1M | $2M |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $169M | — | $-9M | $1M | $-26M | — | $-21M | $-22M |
| Net income | $170M | — | $-8M | $3M | $-25M | — | $-20M | $-20M |
| EPS (diluted) | — | — | — | — | — | — | — | — |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $24M | $18M | $22M | $37M | $37M | $36M | $32M | $63M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $277M | $94M | $97M | $103M | $117M | $127M | $133M | $148M |
| Total assets | $277M | $95M | $98M | $103M | $117M | $132M | $140M | $160M |
| Long-term debt | $0 | — | $0 | $0 | $0 | — | $0 | $0 |
| Total liabilities | $17M | $18M | $20M | $20M | $38M | $34M | $34M | $38M |
| Total equity | $260M | $77M | $77M | $83M | $79M | $97M | $107M | $122M |